Thiazole and imidazo[1,2-a]pyridylhydrazone compounds and their applications
By developing thiazole and imidazolo[1,2-a]pyridinylhydrazone compounds, the problem of decreased pesticide efficacy caused by the resistance of existing bactericidal insecticides and irregular use is solved, and the pesticides has been provided for a variety of agricultural diseases and pests The effective inhibition of drug resistance delays the occurrence of drug resistance and ensures the safety of agricultural production and human health.
Patent Information
- Application Number
- CN202310073525.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-02-07
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2043-02-07
AI Technical Summary
The existing sterilizing pesticides have drug resistance problems, which leads to a decrease in the effectiveness of pesticides. The irregular use of pesticides leads to a decrease in the effectiveness of pesticides, affecting agricultural production and human health.
Develop thiazoles and imidazolo[1,2-a]pyridinyl hydrazone compounds for the preparation of novel heterocyclic hydrazone bacteria and insecticidal activities, providing inhibition against a variety of agricultural diseases and pests active.
This compound shows excellent inhibitory activity against a variety of plant pathogenic fungi and crop pests, and can effectively prevent and treat fungal diseases such as tomato grey mold, potato dry rot, wheat gibberelliasis, as well as pests such as oriental worms and aphids, providing new pesticide selection delays the occurrence of drug resistance.
Smart Images

Figure CN116283822B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of pesticide chemistry, and specifically relates to thiazole and imidazo[1,2-a]pyridylhydrazone compounds and their applications, the effective inhibition of plant pathogenic fungi, oriental armyworms and aphids, and the use of such compounds in preventing and controlling agricultural pathogenic fungal infections and common insect pests. Background Art
[0002] Plant fungal diseases refer to diseases caused by plant pathogenic fungi, mainly including rice blast, gray mold, rust fungi, Fusarium graminearum, Fusarium lanceolate, powdery mildew, anthracnose, corn smut, etc. Several or even dozens of fungal diseases can be found on a crop. Crop diseases and insect pests are also one of the main agricultural disasters. Common diseases and insect pests of crops in my country include oriental armyworm, corn borer, cotton bollworm, cotton aphid, wheat aphid, wheat spider mites, locusts, etc. Plant fungal diseases and crop insect pests have seriously affected my country's agricultural production.
[0003] In recent years, condensed heterocyclic compounds have gradually developed into a bright spot in the development of new drugs. Acylhydrazone is a class of compounds containing amide and imine functional groups. The N-acylhydrazone structure has peptidomimetic properties and can be recognized by a variety of different receptors. In addition, because the nitrogen and oxygen atoms of acylhydrazone have strong coordination ability, it is conducive to forming complexes with most metal ions. By modifying its chemical structure, more highly active heterocyclic substituted acylhydrazone compounds can be obtained, which are widely used in various fields such as agriculture, medicine and industry. In agriculture, acylhydrazone compounds are widely used and are used as herbicides, fungicides and insecticides. In medicine, heterocyclic substituted acylhydrazone compounds have a variety of physiological activities. Acylhydrazone and its metal complexes have been widely used in medicine, analysis and functional materials. Acylhydrazone compounds have antibacterial, antiparasitic, antitumor and enzyme inhibitory activities. In industry, acylhydrazone compounds are used in fluorescence analysis of biomaterials, luminescent materials, dyes and fluorescent probe materials.
[0004] At present, the most widely used fungicides in China include pyraclostrobin, thiophanate-methyl, thiophanate-methyl and ethotripsy. Spirodiclofen, tebufenozide and chlorpyrifos are insecticides with good activity on the market. However, with the development of society, drug resistance is a common problem of existing fungicides and insecticides, and the irregular use of fungicides and insecticides is the main reason for the decline in the effectiveness of pesticides. Therefore, the design and development of new heterocyclic acylhydrazone compounds are of great significance to the development of human life and health and food security. Summary of the invention
[0005] The purpose of the present invention is to explore a new type of highly efficient heterocyclic acylhydrazone fungicide and insecticide, and to provide heterocyclic acylhydrazone derivatives having anti-plant pathogenic bacteria and insecticidal activities.
[0006] The technical solution of the present invention is as follows:
[0007] Thiazole and imidazo[1,2-a]pyridylhydrazone compounds, the compounds comprising:
[0008] A compound of formula I or a pharmaceutically acceptable salt thereof:
[0009]
[0010] In Formula I, R 1 is selected from the group consisting of hydrogen, alkyl, halogen, hydroxyl and haloalkyl;
[0011] R 2 is selected from the group consisting of hydrogen, alkyl, halogen, hydroxyl and haloalkyl;
[0012] R 3 is selected from the group consisting of hydrogen, alkyl, halogen, hydroxy, haloalkoxy, haloalkyl, alkenylalkoxy, and haloalkenylalkoxy;
[0013] R 4 is selected from the group consisting of hydrogen, alkyl, halogen, hydroxyl and haloalkyl;
[0014] R 5 is selected from the group consisting of hydrogen, alkyl, halogen, hydroxyl and haloalkyl;
[0015] And / or a compound of formula II or a pharmaceutically acceptable salt thereof:
[0016]
[0017] In Formula II, R 1 is selected from the group consisting of hydrogen, alkyl, halogen, hydroxyl and haloalkyl;
[0018] R 2 is selected from the group consisting of hydrogen, alkyl, halogen, hydroxyl and haloalkyl;
[0019] R 3 is selected from the group consisting of hydrogen, alkyl, halogen, hydroxy, haloalkoxy, haloalkyl, alkenylalkoxy, and haloalkenylalkoxy;
[0020] R 4 is selected from the group consisting of hydrogen, alkyl, halogen, hydroxyl and haloalkyl;
[0021] R 5 is selected from the group consisting of hydrogen, alkyl, halogen, hydroxyl and haloalkyl;
[0022] R' 1 is selected from the group consisting of hydrogen, alkyl, halogen, hydroxyl and haloalkyl;
[0023] R' 2 is selected from the group consisting of hydrogen, alkyl, halogen, hydroxyl and haloalkyl;
[0024] R'3 is selected from the group consisting of hydrogen, alkyl, halogen, hydroxyl and haloalkyl.
[0025] Optionally, the alkyl group is a straight or branched saturated hydrocarbon group having 1 to 6 carbon atoms; or a cyclic saturated hydrocarbon group having 3 to 6 carbon atoms; or a cyclic saturated hydrocarbon group having 3 to 6 carbon atoms connected to a straight or branched saturated hydrocarbon group having 1 to 6 carbon atoms;
[0026] The haloalkyl group is a straight or branched saturated hydrocarbon group having 1 to 6 carbon atoms, or a cyclic saturated hydrocarbon group having 3 to 6 carbon atoms, or a cyclic saturated hydrocarbon group having 3 to 6 carbon atoms connected to a straight or branched saturated hydrocarbon group having 1 to 6 carbon atoms; wherein one or more carbon atoms are substituted by one or more halogen atoms;
[0027] The alkoxy group is a straight or branched saturated hydrocarbon group having 1 to 6 carbon atoms; or a cyclic saturated hydrocarbon group having 3 to 6 carbon atoms; or a cyclic saturated hydrocarbon group having 3 to 6 carbon atoms connected to a straight or branched saturated hydrocarbon group having 1 to 6 carbon atoms; wherein each carbon atom is optionally substituted by oxygen;
[0028] The alkenyl and alkynyl groups are straight-chain or branched unsaturated hydrocarbon groups with 1 to 6 carbon atoms and containing double bonds or triple bonds;
[0029] The halogen is selected from fluorine, chlorine, bromine and iodine;
[0030] The halogenated unsaturated hydrocarbon group is an alkenyl or alkynyl group as defined above in which one or more carbon atoms are substituted by one or more halogen atoms;
[0031] The haloalkyl group is an alkyl group as defined above connected to a halogen;
[0032] The haloalkoxy group is an alkoxy group as defined above connected to a halogen;
[0033] The alkenyl alkoxy group is connected by an unsaturated hydrocarbon alkoxy group as defined above;
[0034] The haloalkenylalkoxy group is a halogenated unsaturated hydrocarbon alkoxy group as defined above.
[0035] Optionally, R in Formula I 1 is selected from the group consisting of hydrogen, fluorine, chlorine, bromine and hydroxyl;
[0036] R 2 is selected from the group consisting of hydrogen, fluorine, chlorine and bromine;
[0037] R 3 is selected from the group consisting of hydrogen, fluorine, chlorine, bromine, trifluoromethyl, trifluoromethoxy and allyloxy;
[0038] R4 is selected from the group consisting of hydrogen, fluorine, chlorine, bromine and trifluoromethyl;
[0039] R 5 is selected from the group consisting of hydrogen, fluorine, chlorine and bromine.
[0040] Optionally, R in Formula II 1 is selected from the group consisting of hydrogen, fluorine, chlorine, bromine and hydroxyl;
[0041] R 2 is selected from the group consisting of hydrogen, fluorine, chlorine and bromine;
[0042] R 3 is selected from the group consisting of hydrogen, fluorine, chlorine, bromine, trifluoromethyl, trifluoromethoxy and allyloxy;
[0043] R 4 is selected from the group consisting of hydrogen, fluorine, chlorine, bromine and trifluoromethyl;
[0044] R 5 is selected from the group consisting of hydrogen, fluorine, chlorine and bromine;
[0045] R' 1 is selected from hydrogen, chlorine, bromine and benzyloxy;
[0046] R' 2 is selected from the group consisting of hydrogen, chlorine and bromine;
[0047] R' 3 Selected from hydrogen, chlorine and bromine.
[0048] Optionally, the compound of general formula I is preferably a compound of the following structure:
[0049] (E)-N'-(4-(trifluoromethoxy)benzylidene)thiazole-4-carbohydrazide (I-1);
[0050] (E)-N'-(5-chloro-2-fluorobenzylidene)thiazole-4-carbohydrazide (I-2);
[0051] (E)-N'-(2,4-dichlorobenzylidene)thiazole-4-carbohydrazide (I-3);
[0052] (E)-N'-(3,5-dichlorobenzylidene)thiazole-4-carbohydrazide (I-4);
[0053] (E)-N'-(4-(allyloxy)benzylidene)thiazole-4-carbohydrazide (I-5);
[0054] (E)-N'-(3-chlorobenzylidene)thiazole-4-carbohydrazide (I-6);
[0055] (E)-N'-(2,6-chlorobenzylidene)thiazole-4-carbohydrazide (I-7);
[0056] (E)-N'-(3,5-dichloro-2-hydroxybenzylidene)thiazole-4-carbohydrazide (I-8);
[0057] (E)-N'-(2-fluoro-4-(trifluoromethyl)benzylidene)thiazole-4-carbohydrazide (I-9);
[0058] (E)-N'-(2-Fluoro-5-(trifluoromethyl)benzylidene)thiazole-4-carbohydrazide (I-10).
[0059] Optionally, the compound of general formula II is preferably a compound of the following structure:
[0060] (E)-N'-(2-fluoro-5-(trifluoromethyl)benzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-1);
[0061] (E)-N'-(3-chlorobenzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (Ⅱ-2);
[0062] (E)-N'-(5-chloro-2-fluorobenzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-3);
[0063] (E)-N'-(2,6-dichlorobenzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-4);
[0064] (E)-N'-(3,5-dichlorobenzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-5);
[0065] (E)-N'-(4-(allyloxy)benzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-6);
[0066] (E)-N'-(2-bromobenzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-7);
[0067] (E)-N'-(2-fluoro-4-(trifluoromethyl)benzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-8);
[0068] (E)-N'-(4-(Trifluoromethoxy)benzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-9).
[0069] The thiazole and imidazo[1,2-a]pyridylhydrazone compounds of the present invention are used for preparing plant fungicides.
[0070] Optionally, the fungicide is used to prevent and control tomato gray mold, potato dry rot, apple anthracnose, apple rot, rice blast and / or wheat fusarium head blight.
[0071] The thiazole and imidazo[1,2-a]pyridylhydrazone compounds of the present invention are used for preparing botanical insecticides.
[0072] Optionally, the insecticide is used to control armyworms and / or aphids.
[0073] The activity test results of the compounds of the present invention show that the compounds of general formulas I and II have excellent inhibitory activity against potato dry rot fungus (Fusarium solani), tomato gray mold fungus (Botrytis cinerea), wheat fusarium (Fusarium graminearum), apple rot fungus (Cytospora sp.), apple anthracnose fungus (Colletotrichum gloeosporioides) and rice blast fungus (Magnaporthe grisea), and can be used for the preparation of plant fungicides.
[0074] The activity test results show that the compounds of general formula I and II have excellent inhibitory activity against oriental armyworm and can be used in the preparation of botanical insecticides. DETAILED DESCRIPTION
[0075] The technical solution of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0076] The two general formulas of the thiazole and imidazo[1,2-a]pyridylhydrazone compounds of the present invention include:
[0077] A compound of formula I or a pharmaceutically acceptable salt thereof:
[0078]
[0079] In Formula I, R 1 is selected from the group consisting of hydrogen, alkyl, halogen and hydroxy;
[0080] R 2 is selected from the group consisting of hydrogen, alkyl, halogen and hydroxy;
[0081] R 3 is selected from the group consisting of hydrogen, alkyl, halogen, hydroxy, haloalkoxy, haloalkyl, and alkoxyalkenyl;
[0082] R 4 is selected from the group consisting of hydrogen, alkyl, halogen, hydroxyl and haloalkyl;
[0083] R 5is selected from the group consisting of hydrogen, alkyl, halogen and hydroxy;
[0084] And / or a compound of formula II or a pharmaceutically acceptable salt thereof:
[0085]
[0086] In Formula II, R 1 is selected from the group consisting of hydrogen, alkyl, halogen and hydroxy;
[0087] R 2 is selected from the group consisting of hydrogen, alkyl, halogen and hydroxy;
[0088] R 3 is selected from the group consisting of hydrogen, alkyl, halogen, hydroxy, haloalkoxy, haloalkyl, alkenylalkoxy, and haloalkenylalkoxy;
[0089] R 4 is selected from the group consisting of hydrogen, alkyl, halogen, hydroxyl and haloalkyl;
[0090] R 5 is selected from the group consisting of hydrogen, alkyl, halogen and hydroxy;
[0091] R' 1 is selected from hydrogen, alkyl, halogen and alkoxy;
[0092] R' 2 is selected from hydrogen, alkyl, halogen and alkoxy;
[0093] R' 3 is selected from hydrogen, alkyl, halogen and alkoxy.
[0094] The alkyl group is a straight or branched saturated hydrocarbon group having 1 to 6 carbon atoms; or a cyclic saturated hydrocarbon group having 3 to 6 carbon atoms; or a cyclic saturated hydrocarbon group having 3 to 6 carbon atoms connected to a straight or branched saturated hydrocarbon group having 1 to 6 carbon atoms;
[0095] The haloalkyl group is a straight or branched saturated hydrocarbon group having 1 to 6 carbon atoms, or a cyclic saturated hydrocarbon group having 3 to 6 carbon atoms, or a cyclic saturated hydrocarbon group having 3 to 6 carbon atoms connected to a straight or branched saturated hydrocarbon group having 1 to 6 carbon atoms; wherein one or more carbon atoms are substituted by one or more halogen atoms;
[0096] Alkoxy is a straight or branched saturated hydrocarbon group having 1 to 6 carbon atoms; or a cyclic saturated hydrocarbon group having 3 to 6 carbon atoms; or a cyclic saturated hydrocarbon group having 3 to 6 carbon atoms connected to a straight or branched saturated hydrocarbon group having 1 to 6 carbon atoms; wherein each carbon atom is optionally substituted by oxygen;
[0097] Alkenyl and alkynyl are straight-chain or branched unsaturated hydrocarbon groups with 1 to 6 carbon atoms and containing double or triple bonds;
[0098] The halogen is mainly selected from fluorine, chlorine, bromine and iodine substitution;
[0099] The halogenated unsaturated hydrocarbon group is an alkenyl or alkynyl group as defined above in which one or more carbon atoms are substituted by one or more halogen atoms;
[0100] Haloalkyl is an alkyl group as defined above attached to a halogen;
[0101] Haloalkoxy is an alkoxy group as defined above attached to a halogen;
[0102] Alkenylalkoxy is an unsaturated hydrocarbon alkoxy linkage as defined above;
[0103] Haloalkenylalkoxy is a halogenated unsaturated hydrocarbylalkoxy linkage as defined above.
[0104] The preferred embodiment of the present invention is:
[0105] In Formula I, R 1 is selected from the group consisting of hydrogen, fluorine, chlorine, bromine and hydroxyl;
[0106] R 2 is selected from the group consisting of hydrogen, fluorine, chlorine and bromine;
[0107] R 3 is selected from the group consisting of hydrogen, fluorine, chlorine, bromine, trifluoromethyl, trifluoromethoxy and allyloxy;
[0108] R 4 is selected from the group consisting of hydrogen, fluorine, chlorine, bromine and trifluoromethyl;
[0109] R 5 is selected from the group consisting of hydrogen, fluorine, chlorine and bromine;
[0110] In Formula II, R 1 is selected from the group consisting of hydrogen, fluorine, chlorine, bromine and hydroxyl;
[0111] R 2 is selected from the group consisting of hydrogen, fluorine, chlorine and bromine;
[0112] R 3 is selected from the group consisting of hydrogen, fluorine, chlorine, bromine, trifluoromethyl, trifluoromethoxy and allyloxy;
[0113] R 4 is selected from the group consisting of hydrogen, fluorine, chlorine, bromine and trifluoromethyl;
[0114] R 5 is selected from the group consisting of hydrogen, fluorine, chlorine and bromine;
[0115] R' 1 is selected from hydrogen, chlorine, bromine and benzyloxy;
[0116] R' 2 is selected from the group consisting of hydrogen, chlorine and bromine;
[0117] R' 3 Selected from hydrogen, chlorine and bromine.
[0118] The compound of general formula I is preferably a compound of the following structure:
[0119] (E)-N'-(4-(trifluoromethoxy)benzylidene)thiazole-4-carbohydrazide (I-1);
[0120] (E)-N'-(5-chloro-2-fluorobenzylidene)thiazole-4-carbohydrazide (I-2);
[0121] (E)-N'-(2,4-dichlorobenzylidene)thiazole-4-carbohydrazide (I-3);
[0122] (E)-N'-(3,5-dichlorobenzylidene)thiazole-4-carbohydrazide (I-4);
[0123] (E)-N'-(4-(allyloxy)benzylidene)thiazole-4-carbohydrazide (I-5);
[0124] (E)-N'-(3-chlorobenzylidene)thiazole-4-carbohydrazide (I-6);
[0125] (E)-N'-(2,6-chlorobenzylidene)thiazole-4-carbohydrazide (I-7);
[0126] (E)-N'-(3,5-dichloro-2-hydroxybenzylidene)thiazole-4-carbohydrazide (I-8);
[0127] (E)-N'-(2-fluoro-4-(trifluoromethyl)benzylidene)thiazole-4-carbohydrazide (I-9);
[0128] (E)-N'-(2-Fluoro-5-(trifluoromethyl)benzylidene)thiazole-4-carbohydrazide (I-10).
[0129] The compound of general formula II is preferably a compound of the following structure:
[0130] (E)-N'-(2-fluoro-5-(trifluoromethyl)benzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (Ⅱ-1); (E)-N'-(3-chlorobenzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (Ⅱ-2);
[0131] (E)-N'-(5-chloro-2-fluorobenzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-3);
[0132] (E)-N'-(2,6-dichlorobenzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-4);
[0133] (E)-N'-(3,5-dichlorobenzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-5);
[0134] (E)-N'-(4-(allyloxy)benzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-6);
[0135] (E)-N'-(2-bromobenzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-7);
[0136] (E)-N'-(2-fluoro-4-(trifluoromethyl)benzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-8); (E)-N'-(4-(trifluoromethoxy)benzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-9). The preparation method of the compound of the present invention is as follows:
[0137]
[0138] Scheme 1 Synthesis method of heterocyclic acylhydrazone compound Ⅰ. (1) heterocyclic ester raw materials; (2) synthetic intermediates; (3) aldehyde raw materials; (4) acylhydrazone derivatives;
[0139]
[0140] Scheme2 Synthesis of heterocyclic acylhydrazone compounds II. (1) Pyridine raw materials; (2, 3) Synthesis intermediates; (4) Aldehyde raw materials; (5) Acylhydrazone derivatives;
[0141] In the scheme of the present invention, unless otherwise specified, the ratios or percentages mentioned are all based on mass.
[0142] General preparation method of Class I compounds:
[0143] (I) Add thiazole-4-carboxylic acid ethyl ester (100 mg, 0.64 mmol) in anhydrous EtOH (6.4 ml) to a 10 mL eggplant-shaped bottle, add NH2-NH2·H2O (0.2 ml, 10-15 eq), stir at room temperature, and react overnight. Concentrate in vacuo and purify with silica gel column DCM:MeOH (50:1-10:1) to obtain intermediate compound 2 (thiazole-4-carboxylic acid hydrazide) as a white solid.
[0144] (II) Add 2 (thiazole-4-carboxylic acid hydrazide) and 3 in methanol (5 ml) to a 25 ml eggplant-shaped bottle, add 2 drops of glacial acetic acid, and stir the reaction mixture at room temperature overnight. Concentrate in vacuo and purify by silica gel column chromatography with DCM:MeOH (50:1-10:1) to obtain the target compound.
[0145] General preparation method of Class II compounds:
[0146] (I) Pyridine raw material 1 (500 mg, 5.31 mmol) and anhydrous EtOH (10 ml) were added to a 25 mL eggplant-shaped flask, stirred in an ice bath, ethyl 3-bromopyruvate (1.55 g, 7.97 mmol) was added, and refluxed for 24 h; after cooling, the mixture was concentrated in vacuo and purified by silica gel chromatography with DCM:MeOH (100:1-50:1) to obtain intermediate compound 2 as a light yellow solid.
[0147] In a 10 mL eggplant-shaped bottle, add intermediate compound 2 (50 mg, 0.26 mmol), add NH2-NH2·H2O (0.5 ml, excess), stir evenly, reflux at 69°C for 2 h, concentrate in vacuo, purify by silica gel column, and obtain intermediate compound 3 as a white solid using DCM:MeOH (50:1-10:1).
[0148] (II) Add the intermediate compound 3 and the methanol solution (5 ml) of the aldehyde raw material 4 to a 25 ml eggplant-shaped bottle, add 2 drops of glacial acetic acid, stir at room temperature overnight, concentrate in vacuo, and purify by silica gel column chromatography with DCM:MeOH (50:1-10:1) to obtain the target compound.
[0149] Embodiment 1:
[0150] (E)-N'-(4-(trifluoromethoxy)benzylidene)thiazole-4-carbohydrazide (I-1);
[0151]
[0152] The target compound I-1 was prepared by the preparation method of general formula I using thiazole-4-carboxylic acid hydrazide and 4-trifluoromethoxybenzaldehyde to obtain a yellow solid with a yield of 88.63%. 1 H NMR (400MHz, DMSO-d6) δ12.06(s,1H),9.27(d,J=2.0Hz,1H),8.61(s,1H),8.54(d,J=2.0Hz,1H),7.85–7.82(m,2H),7.47–7.44(m,2H). 13 CNMR(100MHz,DMSO-d6)δ157.14,155.33,149.51,149.33,147.08,133.65,129.05,126.16,121.37.
[0153] Embodiment 2:
[0154] (E)-N'-(5-chloro-2-fluorobenzylidene)thiazole-4-carbohydrazide (I-2);
[0155]
[0156] The target compound I-2 was prepared by the preparation method of general formula I using thiazole-4-carboxylic acid hydrazide and 5-chloro-2-fluorobenzaldehyde to obtain a yellow solid with a yield of 96.39%. 1 NMR (400MHz, DMSO-d6) δ12.32(s,1H),9.28(d,J=2.0Hz,1H),8.80(s,1H),8.57(d,J=2.0Hz,1H ),7.89(dd,J=6.2,2.8Hz,1H),7.55(ddd,J=8.9,4.5,2.8Hz,1H),7.38(dd,J=10.1,8.9Hz,1H). 13 C NMR(100MHz,DMSO-d6)δ159.75(d,J=323Hz),157.24,155.37,149.27,139.91(d,J=4.0Hz),131.4 5(d,J=9.0Hz),129.00,126.50,125.39(d,J=3.0Hz),123.88(d,J=12.0Hz),118.24(d,J=23.0Hz).
[0157] Embodiment 3:
[0158] (E)-N'-(2,4-dichlorobenzylidene)thiazole-4-carbohydrazide (I-3);
[0159]
[0160] The target compound I-3 was prepared by the preparation method of general formula I using thiazole-4-carboxylic acid hydrazide and 2,4-dichlorobenzaldehyde to obtain a white solid with a yield of 78.39%. 1 H NMR (400MHz, DMSO-d6) δ12.37(s,1H),9.28(d,J=2.0Hz,1H),8.99(s,1H),8.56( d,J=2.0Hz,1H),8.02(d,J=8.5Hz,1H),7.72(d,J=2.1Hz,1H),7.54–7.49(m,1H). 13 C NMR (100MHz, DMSO-d6) δ157.25,155.31,149.38,143.61,135.12,134.03,130.91,129.40,128.18,128.02,126.38.
[0161] Embodiment 4:
[0162] (E)-N'-(3,5-dichlorobenzylidene)thiazole-4-carbohydrazide (I-4);
[0163]
[0164] The target compound I-4 was prepared by the preparation method of general formula I using thiazole-4-carboxylic acid hydrazide and 3,5-dichlorobenzaldehyde to obtain a yellow solid with a yield of 96.98%. 1 H NMR (400MHz, DMSO-d6) δ12.24(s,1H),9.28(d,J=2.0Hz,1H),8.56(d,J=2.0Hz,1H),8.54(s,1H),7.73(d,J=1.9Hz,2H),7.68(t,J=1.9Hz,1H). 13 C NMR (100MHz, DMSO-d6) δ157.27,155.36,149.30,145.50,138.09,134.66,129.12,126.45,125.36.
[0165] Embodiment 5:
[0166] (E)-N'-(4-(allyloxy)benzylidene)thiazole-4-carbohydrazide (I-5);
[0167]
[0168] The target compound I-5 was prepared by the preparation method of general formula I using thiazole-4-carboxylic acid hydrazide and 4-allyloxybenzaldehyde to obtain a yellow solid with a yield of 88.33%. 1 H NMR (400MHz, DMSO-d6) δ11.82(s,1H),9.26(d,J=2.0Hz,1H),8.52(s,1H),8.50(d,J=2.0Hz,1H),7.68–7.61(m,2H),7. 06–7.00(m,2H),6.05(s,1H),5.41(dq,J=17.3,1.7Hz,1H),5.28(dq,J=10.5,1.5Hz,1H),4.62(dt,J=5.3,1.6Hz,2H). 13 C NMR (100MHz, DMSO-d6) δ159.80,156.85,155.15,149.77,148.49,133.42,128.76,127.03,125.61,117.67,115.03,68.30.
[0169] Embodiment 6:
[0170] (E)-N'-(3-chlorobenzylidene)thiazole-4-carbohydrazide (I-6);
[0171]
[0172] The target compound I-6 was prepared by the preparation method of general formula I using thiazole-4-carboxylic acid hydrazide and 3-chlorobenzaldehyde to obtain a white solid with a yield of 95.64%. 1 H NMR (400MHz, DMSO-d6) δ12.10(s,1H),9.28(d,J=2.0Hz,1H),8.57(s,1H),8.55(d,J=2.0Hz ,1H),7.75(d,J=2.0Hz,1H),7.66(ddd,J=4.7,3.3,1.5Hz,1H),7.50(dd,J=4.0,2.3Hz,2H). 13 C NMR (100MHz, DMSO-d6) δ157.16,155.30,149.45,146.98,136.60,133.68,130.81,129.78,126.24,126.20,125.96.
[0173] Embodiment 7:
[0174] (E)-N'-(2,6-dichlorobenzylidene)thiazole-4-carbohydrazide (I-7);
[0175]
[0176] The target compound I-7 was prepared by the preparation method of general formula I using thiazole-4-carboxylic acid hydrazide and 2,6-dichlorobenzaldehyde to obtain a yellow solid with a yield of 89.58%. 1 H NMR (400MHz, DMSO-d6) δ12.72(s,1H),12.53(s,1H),9.30(d,J=2.0Hz,1H),8.73(s,1H),8.61(d,J=2.0Hz,1H),7.60(dd,J=19.0,2.5Hz,2H). 13 CNMR(100MHz,DMSO-d6)δ157.22,155.34,149.36,144.04,133.94,131.26,130.82,129.06,126.43.
[0177] Embodiment 8:
[0178] (E)-N'-(3,5-dichloro-2-hydroxybenzylidene)thiazole-4-carbohydrazide (I-8);
[0179]
[0180] The target compound I-8 was prepared by the preparation method of general formula I using thiazole-4-carboxylic acid hydrazide and 3,5-dichloro-2-hydroxybenzaldehyde to obtain a yellow solid with a yield of 91.15%. 1 H NMR(400MHz,DMSO-d6)δ12.34(s,1H),9.29(d,J=2.0Hz,1H),8.79(s,1H),8 .55(d,J=2.0Hz,1H),7.58(d,J=0.9Hz,1H),7.56(s,1H),7.47–7.43(m,1H). 13 C NMR (100MHz, DMSO-d6) δ157.16,155.63,152.34,148.64,148.04,130.36,128.49,127.05,122.97,121.54,120.81.
[0181] Embodiment 9:
[0182] (E)-N'-(2-fluoro-4-(trifluoromethyl)benzylidene)thiazole-4-carbohydrazide (I-9);
[0183]
[0184] The target compound I-9 was prepared by the preparation method of general formula I using thiazole-4-carboxylic acid hydrazide and 2-fluoro-4-trifluoromethylbenzaldehyde to obtain a yellow solid with a yield of 93.48%. 1 H NMR (400MHz, DMSO-d6) δ12.38(s,1H),9.29(d,J=2.0Hz,1H),8.88(s,1H),8.58(d,J=2.0 Hz,1H),8.16(t,J=7.7Hz,1H),7.79(dd,J=10.6,1.8Hz,1H),7.68(dd,J=8.2,1.7Hz,1H). 13 C NMR (100MHz, DMSO-d6) δ160.50 (dd, J = 297Hz), 157.28, 155.34, 149.25, 139.86 (d, J = 5.0Hz), 131.34 (dd, J = 33.0, 8.5Hz), 127.64 (d, J = 3.0Hz), 126.53, 126.17 (d, J = 10.0Hz), 123.23 (q, J = 269Hz), 121.70 (t, J = 4Hz), 113.71 (dd, J = 24.0, 4.0Hz).
[0185] Embodiment 10:
[0186] (E)-N'-(2-Fluoro-5-(trifluoromethyl)benzylidene)thiazole-4-carbohydrazide (I-10);
[0187]
[0188] The target compound I-10 was prepared by the preparation method of general formula I using thiazole-4-carboxylic acid hydrazide and 2-fluoro-5-(trifluoromethyl)benzaldehyde to obtain a yellow solid with a yield of 92.96%. 1 H NMR (400MHz, DMSO-d6) δ12.38(s,1H),9.29(d,J=2.0Hz,1H),8.88(s,1H),8.58(d,J=2.0Hz ,1H),8.21(dd,J=6.6,2.4Hz,1H),7.89(td,J=5.0,4.5,2.3Hz,1H),7.57(t,J=9.4Hz,1H). 13 C NMR (100MHz, DMSO-d6) δ162.43(d,J=248.0Hz),157.29,155.39,149.20,139.78(d,J=3.0Hz),128.83(d,J=5.0H z), 126.55, 125.87 (dd, J = 32.0, 3.0Hz), 124.09 (t, J = 190Hz), 123.54–123.25 (m), 122.32, 117.71 (d, J = 22.0Hz).
[0189] Embodiment 11:
[0190] (E)-N'-(2-fluoro-5-(trifluoromethyl)benzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-1);
[0191]
[0192] The target compound II-1 was prepared by the preparation method of general formula II using imidazo[1,2-a]pyridine-2-carboxylic acid hydrazide and 2-fluoro-5-trifluoromethylbenzaldehyde to obtain a yellow solid with a yield of 98.31%. 1 H NMR (400MHz, DMSO-d6) δ12.40(s,1H),8.89(s,1H),8.62(d,J=6.8Hz,1H),8.59(s,1H),8.21(dd,J=6.5,2.5Hz,1H),7. 90–7.85(m,1H),7.65(d,J=9.2Hz,1H),7.56(t,J=9.4Hz,1H),7.40(ddd,J=8.9,6.8,1.3Hz,1H),7.03(t,J=6.7Hz,1H).13 C NMR(100MHz, DMSO-d6)δ162.32(d,J=233.0Hz),158.95,144.05,139.03(d,J=4.0Hz),138.14,129.66,129.16–128.53(m),127.79 ,126.83,125.86(dd,J=33.0,3.0Hz),123.55–123.18(m),122.37(d,J=270.0Hz),117.71(d,J=23.0Hz),117.35,116.30,113.54.
[0193] Embodiment 12:
[0194] (E)-N'-(3-chlorobenzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (Ⅱ-2);
[0195]
[0196] The target compound II-2 was prepared by the preparation method of general formula II using imidazo[1,2-a]pyridine-2-carboxylic acid hydrazide and 3-chlorobenzaldehyde to obtain a white solid with a yield of 89.86%. 1 H NMR (400MHz, DMSO-d6) δ12.08(s,1H),8.62(dt,J=6.9,1.2Hz,1H),8.57(d,J=11.0Hz,2H),7.75(q,J=1.5Hz ,1H),7.68–7.61(m,2H),7.54–7.45(m,2H),7.39(ddd,J=9.2,6.7,1.3Hz,1H),7.03(td,J=6.8,1.1Hz,1H). 13 CNMR(100MHz,DMSO-d6)δ158.77,146.34,144.03,138.36,136.80,133.70, 130.85,129.67,127.80,126.80,126.16,125.93,117.35,116.09,113.51.
[0197] Embodiment 13:
[0198] (E)-N'-(5-chloro-2-fluorobenzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-3);
[0199]
[0200] The target compound II-3 was prepared by the preparation method of general formula II using imidazo[1,2-a]pyridine-2-carboxylic acid hydrazide and 5-chloro-2-fluorobenzaldehyde to obtain a white solid with a yield of 91.39%. 1 H NMR (400MHz, DMSO-d6) δ12.33(s,1H),8.81(s,1H),8.62(dt,J=6.9,1.2Hz,1H),8.57(s,1H),7.90(dd,J=6.1 ,2.8Hz,1H),7.65(dq,J=9.3,1.0Hz,1H),7.56–7.52(m,1H),7.42–7.35(m,2H),7.03(td,J=6.8,1.2Hz,1H). 13 CNMR(100MHz,DMSO-d6)δ159.45(d,J=270.0Hz),158.91,144.05,139.22(d,J=4.0Hz),138.20,131.30(d,J=8.0Hz),129.0 0(d,J=3.0Hz),127.80,126.83,125.36(d,J=2.0Hz),124.08(d,J=12.0Hz),118.25(d,J=23.0Hz),117.36,116.25,113.54.
[0201] Embodiment 14:
[0202] (E)-N'-(2,6-dichlorobenzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-4);
[0203]
[0204] The target compound II-4 was prepared by the preparation method of general formula II using imidazo[1,2-a]pyridine-2-carboxylic acid hydrazide and 2,6-dichlorobenzaldehyde to obtain a white solid with a yield of 95.18%. 1 H NMR (400MHz, DMSO-d6) δ12.32(s,1H),8.80(s,1H),8.65–8.61(m,1H),8.56–8.54(m,1H),7.65(dd,J=9.2,1.2 Hz,1H),7.59–7.56(m,2H),7.47–7.44(m,1H),7.40(ddd,J=9.2,6.7,1.3Hz,1H),7.03(td,J=6.8,1.2Hz,1H). 13C NMR (100MHz, DMSO-d6) δ158.84,144.05,143.43,138.30,133.97,131.21,130.98,129.08,127.82,126.81,117.38,116.19,113.53.
[0205] Embodiment 15:
[0206] (E)-N'-(3,5-dichlorobenzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-5);
[0207]
[0208] The target compound II-5 was prepared by the preparation method of general formula II using imidazo[1,2-a]pyridine-2-carboxylic acid hydrazide and 3,5-dichlorobenzaldehyde to obtain a white solid with a yield of 91.22%. 1 H NMR (400MHz, DMSO-d6) δ12.22(s,1H),8.62(dt,J=6.9,1.3Hz,1H),8.56(d,J=5.3Hz,2H),7.72(d,J=2.0Hz,2H),7 .68(t,J=1.9Hz,1H),7.64(dt,J=9.1,1.1Hz,1H),7.39(ddd,J=9.2,6.7,1.3Hz,1H),7.03(td,J=6.7,1.2Hz,1H). 13 C NMR (100MHz, DMSO-d6) δ158.89,144.85,144.03,138.28,138.21,134.68,129.00,127.80,126.83,125.29,117.36,116.21,113.54.
[0209] Embodiment 16:
[0210] (E)-N'-(4-(allyloxy)benzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-6);
[0211]
[0212] The target compound II-6 was prepared by the preparation method of general formula II using imidazo[1,2-a]pyridine-2-carboxylic acid hydrazide and 4-allyloxybenzaldehyde to obtain a white solid with a yield of 98.04%. 1H NMR (400MHz, DMSO-d6) δ11.79(s,1H),8.61(dd,J=6.9,1.3Hz,1H),8.54–8.52(m,2H),7.65–7.62(m,3H),7.40–7.36(m,1H ),7.05–7.01(m,3H),6.06(m,1H),5.41(dq,J=17.3,1.7Hz,1H),5.28(dq,J=10.5,1.5Hz,1H),4.62(dt,J=5.3,1.6Hz,2H). 13 C NMR(100MHz,DMSO-d6)δ159.72,158.41,147.84,143.97,138.70,133.47,128 .68,127.75,127.21,126.66,117.71,117.30,115.77,115.05,113.39,68.31.
[0213] Embodiment 17:
[0214] (E)-N'-(2-bromobenzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-7);
[0215]
[0216] The target compound II-7 was prepared by the preparation method of general formula II using imidazo[1,2-a]pyridine-2-carboxylic acid hydrazide and 2-bromobenzaldehyde to obtain a white solid with a yield of 82.14%. 1 H NMR(400MHz,DMSO-d6)δ12.35(s,1H),8.99(s,1H),8.62(d,J=6.6Hz,1H),8.56(s,1H),8 .01(dd,J=7.9,1.8Hz,1H),7.73–7.59(m,2H),7.47(t,J=7.6Hz,1H),7.43–7.32(m,2H). 13 C NMR(100MHz,DMSO-d6)δ158.91,146.48,144.04,138.44,133.49,133.21, 131.67,128.11,127.79,127.37,126.77,123.63,117.37,116.12,113.50.
[0217] Embodiment 18:
[0218] (E)-N'-(2-fluoro-4-(trifluoromethyl)benzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-8);
[0219]
[0220] The target compound II-8 was prepared by the preparation method of general formula II using imidazo[1,2-a]pyridine-2-carboxylic acid hydrazide and 2-fluoro-4-trifluoromethylbenzaldehyde to obtain a yellow solid with a yield of 93.28%. 1 H NMR (400MHz, DMSO-d6) δ12.40(s,1H),8.89(s,1H),8.62(d,J=6.9Hz,1H),8.58(s,1H),8.16(t ,J=7.7Hz,1H),7.81–7.76(m,1H),7.69–7.64(m,2H),7.42–7.37(m,1H),7.03(t,J=6.7Hz,1H). 13 C NMR(100MHz,DMSO-d6)δ160.24(d,J=251.0Hz),158.96,144.06,139.16(d,J=4.0Hz),138.17,133.19,127.82,127 .59(d,J=3.0Hz),126.86,126.39(d,J=11.0Hz),121.75(d,J=5.0Hz),117.38,116.31,114.08–113.60(m),113.57.
[0221] Embodiment 19:
[0222] (E)-N'-(4-(trifluoromethoxy)benzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-9);
[0223]
[0224] The target compound II-9 was prepared by the preparation method of general formula II using imidazo[1,2-a]pyridine-2-carboxylic acid hydrazide and 4-trifluoromethoxybenzaldehyde to obtain a yellow solid with a yield of 98.14%. 1 H NMR (400MHz, DMSO-d6) δ12.04(s,1H),8.62(d,J=7.3Hz,2H),8.55(s,1H),7.83(d,J=8.5Hz,2H), 7.64(d,J=9.2Hz,1H),7.45(d,J=8.3Hz,2H),7.39(dd,J=9.2,6.5Hz,1H),7.02(t,J=6.8Hz,1H). 13C NMR(100MHz,DMSO-d6)δ158.75,149.25,146.43,144.04,138.43,133.84,12 8.97,127.81,126.81,122.40(q,J=126Hz),121.40,117.36,116.05,113.51.
[0225] The compounds of the present invention can be prepared by the above method or a method similar to the above method, and the corresponding raw materials can be selected according to the different substituents and the different positions of the substituents.
[0226] (I) Activity test results show that the compounds of general formula I and II have excellent inhibitory activity against potato dry rot fungus (Fusarium solani), tomato gray mold fungus (Botrytis cinerea), wheat head blight fungus (Fusarium graminearum), apple rot fungus (Cytospora sp.), apple anthracnose fungus (Colletotrichum gloeosporioides) and rice blast fungus (Magnaporthe grisea).
[0227] The following are some activity evaluation experiments and results
[0228] The inhibitory activity of all compounds against different plant-derived fungi was determined by mycelium growth rate method and compared with positive control drugs to screen out compounds with good activity.
[0229] Specific method: Prepare the compound to be screened into a 10 mg / mL mother solution, take 75 μL (50 ppm, the same below) and add it to 20 mL of solid culture medium and mix it quickly. The test strain needs to be activated in advance, and a sufficient number of bacterial cakes are prepared with a puncher with an inner diameter of 5 mm for use. Use a sterile inoculation needle to place the bacterial cake on the solidified culture medium, with the mycelium side facing down, and gently press to make the bacterial cake in close contact with the culture medium. Place three bacterial cakes of the same pathogenic fungus in each culture dish. The culture dish with the inoculated bacteria is placed in a constant temperature incubator at 26℃-28℃ for dark culture. After 48 to 96 hours, use a ruler to measure the radial length of the fungal colony (cross method, take the average value).
[0230] The corresponding DMSO solvent system was used as the blank control, and carbendazim was used as the positive control. Inhibition rate (%) = inhibition rate (%) = (C–T) / (C–5mm) × 100%, C is the colony diameter (mm) of the blank control group, and T is the colony diameter (mm) of the treatment group or the positive control group. LC 50 The values were determined by the inhibition rates at different concentration gradients, and the fitting plots were calculated using IBM SPSS Statistics 21.
[0231] Table 1 Toxicity of some compounds to tomato gray mold, potato dry rot and apple anthracnose
[0232]
[0233] Table 2 Toxicity of some compounds to apple rot pathogen, rice blast pathogen and wheat fusarium rust pathogen
[0234]
[0235] (II) The activity test results show that the compounds of formula I and II have excellent inhibitory activity against oriental armyworm.
[0236] The inhibitory activity of all compounds against the third-instar oriental armyworm was determined by leaf dipping method and compared with the blank group and negative group to screen out the compounds with good activity.
[0237] Specific method: Select 3rd-instar oriental armyworms of uniform size and good health and place them in a 24-well plate. Prepare the compound to be screened into a 1 mg / mL stock solution. Take an appropriate amount of fresh and clean leaves and cut them into 0.5 mm squares for later use. Immerse the leaves in the solution of the test agent, take them out after 10 seconds and place them in a petri dish to dry, and place an equal amount in a 24-well plate containing oriental armyworms. Observe and record the results after 24 hours and 48 hours.
[0238] The following are some activity evaluation experiments and results:
[0239] Table 3 Insecticidal activity of compounds at 1.0 mg / mL against third-instar oriental armyworm
[0240]
[0241] a The mortality rate of celangulin V (CV) against oriental armyworm at 10.0 mg / mL
[0242] Table 4 LD of some compounds against oriental armyworm (3rd instar) after 48 hours of treatment 50 value
[0243]
[0244] (III) Activity test results show that the compounds of formula I and II have excellent inhibitory activity against aphids.
[0245] The inhibitory activity of all compounds against wingless pea aphids was tested and compared with the blank group and the negative group to screen out the compounds with good activity.
[0246] Specific method: 20-30 wingless pea aphids in good health were randomly selected and placed on pea leaves. 0.1 mg of the compound to be screened was dissolved in 200 μL of acetone, and the agent was diluted with 0.1% tween 80% aqueous solution to prepare a 100 mg / L mother solution. The leaves were placed in the solution for 10 seconds. After 24 hours, the death of the test insects was detected and the results were recorded.
[0247] The following are some activity evaluation experiments and results:
[0248] Table 5 LD of some compounds against wingless pea aphids 24 hours after treatment 50 value
[0249]
[0250] The preferred embodiments of the present disclosure are described in detail above; however, the present disclosure is not limited to the specific details in the above embodiments. Within the technical concept of the present disclosure, a variety of simple modifications can be made to the technical solution of the present disclosure, and these simple modifications all fall within the protection scope of the present disclosure.
[0251] It should also be noted that the various specific technical features described in the above specific embodiments can be combined in any suitable manner without contradiction. In order to avoid unnecessary repetition, the present disclosure will not further describe various possible combinations.
[0252] In addition, various embodiments of the present disclosure may be arbitrarily combined, and as long as they do not violate the concept of the present disclosure, they should also be regarded as the contents disclosed by the present disclosure.
Claims
1. Thiazole and imidazo[1,2-a]pyridylhydrazone compounds, characterized in that: A compound having the following structure: (E)-N'-(4-(trifluoromethoxy)benzylidene)thiazole-4-carbohydrazide (I-1); (E)-N'-(5-chloro-2-fluorobenzylidene)thiazole-4-carbohydrazide (I-2); (E)-N'-(2,4-dichlorobenzylidene)thiazole-4-carbohydrazide (I-3); (E)-N'-(3,5-dichlorobenzylidene)thiazole-4-carbohydrazide (I-4); (E)-N'-(4-(allyloxy)benzylidene)thiazole-4-carbohydrazide (I-5); (E)-N'-(3-chlorobenzylidene)thiazole-4-carbohydrazide (I-6); (E)-N'-(2,6-chlorobenzylidene)thiazole-4-carbohydrazide (I-7); (E)-N'-(3,5-dichloro-2-hydroxybenzylidene)thiazole-4-carbohydrazide (I-8); (E)-N'-(2-fluoro-4-(trifluoromethyl)benzylidene)thiazole-4-carbohydrazide (I-9); (E)-N'-(2-Fluoro-5-(trifluoromethyl)benzylidene)thiazole-4-carbohydrazide (I-10); (E)-N'-(2-fluoro-5-(trifluoromethyl)benzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-1); (E)-N'-(3-chlorobenzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (Ⅱ-2); (E)-N'-(5-chloro-2-fluorobenzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-3); (E)-N'-(2,6-dichlorobenzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-4); (E)-N'-(3,5-dichlorobenzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-5); (E)-N'-(4-(allyloxy)benzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-6); (E)-N'-(2-bromobenzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-7); (E)-N'-(2-fluoro-4-(trifluoromethyl)benzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-8); (E)-N'-(4-(Trifluoromethoxy)benzylidene)imidazo[1,2-a]pyridine-2-carbohydrazide (II-9).
2. Use of the thiazole and imidazo[1,2-a]pyridylhydrazone compounds according to claim 1 for preparing plant fungicides; The fungicide is used for preventing and controlling tomato gray mold, potato dry rot, apple anthracnose, apple rot and / or rice blast.
3. Use of the thiazole and imidazo[1,2-a]pyridylhydrazone compounds according to claim 1 for preparing botanical insecticides; The insecticide is used for preventing and controlling armyworms and / or aphids.
